Australia markets closed

NanJing Research Institute of Surveying, Mapping & Geotechnical Investigation, Co.Ltd (300826.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
12.01+0.09 (+0.76%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 1.88B
Enterprise value 1.31B
Trailing P/E 43.25
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.24
Price/book (mrq)1.49
Enterprise value/revenue 1.74
Enterprise value/EBITDA 17.65

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-15.16%
S&P500 52-week change 326.94%
52-week high 322.95
52-week low 38.61
50-day moving average 312.61
200-day moving average 315.57

Share statistics

Avg vol (3-month) 35.02M
Avg vol (10-day) 34.85M
Shares outstanding 5157.88M
Implied shares outstanding 6160.39M
Float 868.54M
% held by insiders 153.43%
% held by institutions 13.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.2
Forward annual dividend yield 41.65%
Trailing annual dividend rate 30.10
Trailing annual dividend yield 30.84%
5-year average dividend yield 4N/A
Payout ratio 471.43%
Dividend date 3N/A
Ex-dividend date 411 July 2023
Last split factor 21.3:1
Last split date 315 June 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.20%
Operating margin (ttm)3.55%

Management effectiveness

Return on assets (ttm)0.96%
Return on equity (ttm)3.53%

Income statement

Revenue (ttm)770.34M
Revenue per share (ttm)5.40
Quarterly revenue growth (yoy)4.60%
Gross profit (ttm)N/A
EBITDA 59.67M
Net income avi to common (ttm)40.08M
Diluted EPS (ttm)0.28
Quarterly earnings growth (yoy)-46.40%

Balance sheet

Total cash (mrq)759.56M
Total cash per share (mrq)5.4
Total debt (mrq)185.39M
Total debt/equity (mrq)13.93%
Current ratio (mrq)2.08
Book value per share (mrq)9.14

Cash flow statement

Operating cash flow (ttm)94.8M
Levered free cash flow (ttm)23.59M